Induction chemotherapy with concurrent chemoradiotherapy versus concurrent chemoradiotherapy for locally advanced squamous cell carcinoma of head and neck: a meta-analysis

Documenti analoghi

• Cisplatin-Based Chemotherapy versus Cetuximab in Concurrent Chemoradiotherapy for Locally Advanced Head and Neck Cancer Treatment
  di: Hu, Ming-Hung, et al.
  Pubblicazione: (2014)
• Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy with or without adjuvant chemotherapy for locally advanced nasopharyngeal carcinoma
  di: Zhou, Zhi Rui, et al.
  Pubblicazione: (2018)
• Concurrent Chemoradiotherapy With Cisplatin Versus Cetuximab for Squamous Cell Carcinoma of the Head and Neck
  di: Riaz, Nadeem, et al.
  Pubblicazione: (2016)
• Induction chemotherapy with paclitaxel, ifosfamide, and cisplatin followed by concurrent chemoradiotherapy for unresectable locally advanced head and neck cancer
  di: Chitapanarux, I, et al.
  Pubblicazione: (2010)
• The Efficacy of an Induction Chemotherapy Combination with Docetaxel, Cisplatin, and 5-FU Followed by Concurrent Chemoradiotherapy in Advanced Head and Neck Cancer
  di: Ahn, Jae-Sook, et al.
  Pubblicazione: (2007)